INNATE | ADAPTIVE | |
COMPONENTS |
Neutrophils, macrophages, monocytes, dendritic cells, natural killer (NK) cells (lymphoid origin), complement, physical epithelial barriers, secreted enzymes |
T cells, B cells, circulating antibodies |
MECHANISM |
Germline encoded |
Variation through V(D)J recombination during lymphocyte development |
RESPONSE TO PATHOGENS |
Nonspecific Occurs rapidly (minutes to hours) No memory response |
Highly specific, refined over time Develops over long periods; memory response is faster and more robust |
SECRETED PROTEINS |
Lysozyme, complement, C-reactive protein (CRP), defensins, cytokines |
Immunoglobulins, cytokines |
KEY FEATURES IN PATHOGEN RECOGNITION |
Toll-like receptors (TLRs): pattern recognition receptors that recognize pathogen-associated molecular patterns (PAMPs) and lead to activation of NF-κB Examples of PAMPs: LPS (gram ⊝ bacteria), flagellin (bacteria), nucleic acids (viruses) |
Memory cells: activated B and T cells; subsequent exposure to a previously encountered antigen > stronger, quicker immune response |
PASSIVE | ACTIVE | |
MEANS OF ACQUISITION |
Receiving preformed antibodies |
Exposure to exogenous antigens |
ONSET |
Rapid |
Slow |
DURATION |
Short span of antibodies (half-life = 3 weeks) |
Long-lasting protection (memory) |
EXAMPLES |
IgA in breast milk, maternal IgG crossing placenta, antitoxin, humanized monoclonal antibody |
Natural infection, vaccines, toxoid |
NOTES |
After exposure to tetanus toxin, HBV, varicella, rabies virus, botulinum toxin, or diphtheria toxin, unvaccinated patients are given preformed antibodies (passive)—“to Heal very rapidly before dying” |
Combined passive and active immunizations can be given for hepatitis B or rabies exposure |
MYELOID CELLS Granulocytes Monocytes Macrophages Dendritic | LYMPHOID CELLS B T ILC |
OTHERS Stromal Epithelial Pericytes M |
HEMATOPOIESIS Lymphopoiesis Myelopoiesis |
ANTIGEN RECEPTORS B T | PRRs Membrane bound Cytoplasmic Secreted |
COMPLEMENT Rs |
Fc Rs |
CYTOKINE Rs |
NK Rs |
OTHERS Rs |
ANTIBODIES A D E G M |
CYTOKINES Chemokines Interferons Interleukins TNFs CSFs |
MHCs I II |
COMPLEMENT PROTEINS Early Stage Middle Late Inhibitors |
ANTIMICROBIAL PEPTIDES | TF |
SIGNALING PATHWAYS |
CAMs |
OTHERS |
IDIOPATHIC INFLAMMATION |
CANCER TUMOR |
AMYLOIDOSIS | PREDICTING IMMUNOGENICITY |
MUSCULOSKELETAL |
CONNECTIVE & VASCULITIS |
SKIN |
REPRODUCTION |